Eli Lilly (LLY), Incyte (INCY) Achieve Primary Endpoint in Baricitinib Phase IIb as JAK Inhibitor

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/20/2026

1. BA
2. SPY
3. USO
4. XFLT
5. AMC
6. GE
7. RTX
8. EVEX
9. TRV
10. DPZ

Go back to Eli Lilly (LLY), Incyte (INCY) Achieve Primary Endpoint in Baricitinib Phase IIb as JAK Inhibitor